Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint TherapyZhuangzhuang Zhang, Xiaoqi Liu, Jie Li et al.|Cancer Research|2022Cited by 68
PI3K/mTOR Dual Inhibitor PF-04691502 Is a Schedule-Dependent Radiosensitizer for Gastroenteropancreatic Neuroendocrine TumorsZeta Chow, Piotr Rychahou|Cells|2021Cited by 20
Inhibition of ribonucleotide reductase subunit M2 enhances the radiosensitivity of metastatic pancreatic neuroendocrine tumorZeta Chow, Piotr Rychahou|Cancer Letters|2024Cited by 8